3-(5-Bromo-2-methoxyphenyl)-1-methylpyrazole | 1360444-97-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-(5-Bromo-2-methoxyphenyl)-1-methylpyrazole
• 英文别名: 3-(5-bromo-2-methoxyphenyl)-1-methylpyrazole
• CAS: 1360444-97-8
• 化学式: C₁₁H₁₁BrN₂O
• 分子量: 267.125
• InChiKey: UUVSWLJYDLJERP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.86
• 重原子数：
  15.0
• 可旋转键数：
  2.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  27.05
• 氢给体数：
  0.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  3-(5-Bromo-2-methoxyphenyl)-1-methylpyrazole 在 四(三苯基膦)钯 、 三氟二甲基硫醚络合物 作用下， 以 乙二醇二甲醚 、 二氯甲烷 、 1,2-二氯乙烷 为溶剂， 反应 16.67h， 生成 4-(2-Methoxy-5-prop-2-enylphenyl)-2-(1-methylpyrazol-3-yl)phenol
  参考文献：
  名称：

  Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity

  摘要：

  A versatile synthetic route is reported towards the preparation of new analogues for potent neurotrophic agent biaryl-type lignan honokiol. A focused 24-membered library of derivatives containing five different groups at 5'-position of honokiol has been prepared in fair to good overall yields. Compared to the natural product, or to analogues with a short alkyl chain in this position, these new derivatives have lost most of the neurotrophic activity. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.015
• 作为产物：
  描述：

  5-溴-2-甲氧基苯甲醛 在 Jones reagent 作用下， 以 四氢呋喃 、 乙醇 、 丙酮 为溶剂， 反应 8.5h， 生成 3-(5-Bromo-2-methoxyphenyl)-1-methylpyrazole
  参考文献：
  名称：

  Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity

  摘要：

  A versatile synthetic route is reported towards the preparation of new analogues for potent neurotrophic agent biaryl-type lignan honokiol. A focused 24-membered library of derivatives containing five different groups at 5'-position of honokiol has been prepared in fair to good overall yields. Compared to the natural product, or to analogues with a short alkyl chain in this position, these new derivatives have lost most of the neurotrophic activity. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.015

文献信息

• [EN] PURINES AND METHODS OF THEIR USE<br/>[FR] PURINES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：[en]KINETA, INC.

  公开号：WO2023107552A2

  公开（公告）日：2023-06-15

  Disclosed are compounds useful in the treatment of neurological disorders. The compounds described herein, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological diseases.